Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating

Leuk Lymphoma. 2009 Mar;50(3):323-4. doi: 10.1080/10428190902779257.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Humans
  • Leukoencephalopathy, Progressive Multifocal / drug therapy*
  • Leukoencephalopathy, Progressive Multifocal / immunology
  • Risk Assessment
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab